Alzheimer's Disease Clinical Trials in San Antonio

Showing 141-160 of 202 trials

Phase III Study of Florbetaben (BAY94-9172) PET Imaging for Detection/Exclusion of Cerebral β-amyloid Compared to Histopathology

NCT01020838

To determine the sensitivity and specificity of the visual assessment of tracer uptake in the Florbetaben PET images compared to histological verification of the presence or absence of cerebral β-amyloid in the respective histopathologic post mortem specimens as the standard of truth

Alzheimer Disease

Lantheus Biosciences Ltd.218 participantsStarted Nov 2009

Sun City, Arizona, United States • Stanford, California, United States • Tampa, Florida, United States +16 more locations

TERMINATEDPhase 3< 1 mile

Study of the Safety and Clinical Effects of 2 Doses of EVP-6124 in Subjects With Alzheimer's Disease Who Complete Study EVP-6124-024 or EVP-6124-025

NCT02004392

This is a 26-week, randomized extension of the Phase 3 double-blind placebo-controlled studies, EVP-6124-024 and EVP-6124-025. In this extension study, subjects who complete study EVP-6124-024 or EVP-6124-025 and fulfill all entry criteria will be randomized to receive EVP-6124 for an additional 26 weeks.

Alzheimer's DiseaseDementia

FORUM Pharmaceuticals Inc348 participantsStarted Jun 2014

Phoenix, Arizona, United States • Tucson, Arizona, United States • Little Rock, Arkansas, United States +83 more locations

Phase III Study of Florbetaben (BAY94-9172) PET Imaging for Detection/Exclusion of Cerebral β-amyloid Compared to Histopathology

Study of the Safety and Clinical Effects of 2 Doses of EVP-6124 in Subjects With Alzheimer's Disease Who Complete Study EVP-6124-024 or EVP-6124-025

Alzheimer's Disease Trials in Other Cities

Study of the Pharmacokinetics and Pharmacodynamics of POSIPHEN® in Subjects With Amnestic Mild Cognitive Impairment

Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease

A Study of SB-742457, Added to Donepezil for the Treatment of Mild-to-moderate Alzheimer's Disease

Treatment for Aggression and Agitation in Patients With Alzheimer's Disease

Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease

Study Evaluating TheSafety And Efficacy Of PF-05212377 Or Placebo In Subjects With Alzheimer's Disease With Existing Neuropsychiatric Symptoms On Donepezil

Idalopirdine in Patients With Mild-moderate Alzheimer's Disease Treated With Donepezil

Amyloid Imaging And Safety Study Of ACC-001 In Subjects With Early Alzheimer's Disease

A Study of RO4602522 in Participants With Moderate Severity Alzheimer Disease on Background Alzheimer Disease Therapy

Open-label Study of Flexible-dose Paliperidone ER (Extended Release) to Treat Adolescent Schizophrenia.

A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of [18F]NAV4694 PET for Detection of Cerebral Beta-Amyloid When Compared With Postmortem Histopathology

Coordinating Center for Caregiver Intervention Trial

A Long Term Extension Study Evaluating ACC-001 With QS-21 in Subjects With Mild to Moderate Alzheimer's Disease

Study Evaluating ACC-001 In Subjects With Mild To Moderate Alzheimer's Disease

A Study of the Safety and Tolerability of AZD5213 Effect on Sleep for Patients With Alzheimer's/Cognitive Impairment

Effect of NeuroAD on the Cognitive Function of Alzheimer Patients

Safety and Tolerability of Dimebon in Patients on Memantine, and Memantine Plus Donepezil

Efficacy Study of a ZT-1 Implant in Patients Suffering From Alzheimer's Disease

Other Conditions in San Antonio